Tulio E. Bertorini, M.D.

Professor, Department of Neurology
Professor, Department of Pathology
Chief of Neurology, Methodist University Hospital
Director, Neuromuscular Disease Fellowship Training

Education

B.A. M.D.

San Marcos Univ. School of Science, Peru San Marcos Univ. School of Science, Peru

1963 1970

Post-Graduate Training

Internship Internship Neurology Residency Special Trainee Clinical Associate

Hospital del Empleado, Peru Union Memorial Hospital, MD Georgetown University Massachusetts General Hospital NINCDS, HIH, Bethesda, MD

1970-1971 1971-1972 1972-1975 1975 1975-1977

Professional Experience

Instructor Associate Professor Assistant Professor Associate Professor Professor Professor Director of Neurology Director of Residency Program Co-Director of Residency Program

San Marcos Univ., Peru U.T. Memphis Neurology U.T. Memphis Pathology U.T. Memphis Pathology U.T. Memphis Neurology U.T. Memphis Pathology Methodist Hospital, Memphis U.T. Memphis Neurology U.T. Memphis Neurology

1970-1971 1977-1988 1978-1982 1982-1989 1988-present 1989-present 1990-present 1985-1992 1992-present

Professional Certification & Licensing

Diplomate EMG Certification Clinical Neurophysiology Medical License Medical License Medical License

Am. Board of Psych. and Neurology Am. Assoc. of Electrodiagnostid Med. Am. Board of Psych. and Neurology District of Columbia Maryland Tennessee

1977 1980 1996 1975 1982 1977

Clinical Subspecialty Expertise

Clinical Neuromuscular Diseases; EMG; Muscle Nerve Histopathology

Research Interests

Muscular Dystrophy and other Neuromuscular Diseases, Clinical Trials; Clinical Neurophysiology; Neuromuscular Histopathology

Representative Publications

Bertorini TE, Nance A, Horner LH, Greene W, Gelfand MS, Jaster JH. Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 19(3):388-391, 1996.

DCCT Research Group. Effects of intensive diabetes therapy on neuropsychological function in adults in the diabetes control and complications trial. Annals of Internal Medicine 124:379-388, 1996.

Elsehety A, Bertorini TE. Neurological and Neuropsychiatric Complications of Crohn’s Disease. Southern Medical Journal 90(6):606-610, 1997.

Bertorini TE, Bhattacharya SK, Palmieri GMA, Chesney CM, Pifer D, Baker B. Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 32:1088-1092, 1982.

Bertorini TE, Shively V, Taylor B, Palmieri GMA, Fox IH. ATP degradation products after ischemic exercise: hereditary lack of phosphorylase of carnitine palmityltransferase. Neurology 35:1355-1357, 1985.

Bertorini TE, Yeh Y, Trevison C, Stadlan E, Sabesin S, DiMauro S. Carnitine palmityl transferase deficiency: myoglobinuria and respiratory failure. Neurology 30:263-271, 1980.

Bertorini TE, Palmieri GM, Griffin JW. Effects of chronic treatment of diltiazem in Duchenne muscular dystrophy. Neurology 38:609-613, 1988.

Bertorini TE, Stalberg E, Yuson CP, Engel WK. Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings. Muscle & Nerve 17:345-353, 1994.

Nutting DF, Schriock EA, Palmieri GM, Bittle JB, Elmendorf BJ, Horner LH, Edwards MC, Griffin JW, Sacks HS, Bertorini TE. Octreotide enhances positive calcium balance in Duchenne muscular dystrophy. American Journal of Medical Science 310(3):91-98, 1995.

Moufarrej NA, Bertorini TE. Respiratory insufficiency in adult acid maltase deficiency. Southern Medical Journal 86(5):560-567, 1993.

Bedlack RS, Bertorini TE, Sanders DB. Hidden afterdischarges in slow channel congenital myasthenic syndrome. J Clin Neuromusc Dis 1:186-189, 2000.

Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Randell M, Vinik A, Giuliani M, Stevens JC, Barbano R, Dyck PJ and the rhNGF Clinical Investigator Group. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy. A randomized controlled trial. JAMA 284(17):2215-2221, 2000.

Narayanaswami P, Bertorini TE. Progressive amyotrophy as a late complication of myelopathy. J Neurol Sci 184(1):11-13, 2001.

Narayanaswami P, Bertorini TE. The dropped head syndrome. J Clin Neuromusc Dis 2(2):106-112, 2000.

Bertorini T, Narayanaswami P. Autoimmune Neuropathies. Comprehensive Therapy 2003; 29 (4): 194-209.

Bertorini T, Narayanaswami P, Rashed H. Charcot-Marie-Tooth disease (hereditary motor sensory neuropathies) and hereditary sensory and autonomic neuropathies.Neurologist. 2004 Nov;10(6):327-37.

Escolar DM, Buyse G, Henricson E, Leshner R, Florence J, Mayhew J, Tesi-Rocha C, Gorni K, Pasquali L, Patel KM, McCarter R, Huang J, Mayhew T, Bertorini T, Carlo J, Connolly A, Clemens P, Goemans N, Iannaccone S, Igarashi M, Nevo Y, Pestronk A, Subramony SH, Vedanarayanan VV, Wessel H, and the CINRG group.

Randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy . Annals Neurol. Jul: 58 (1): 151-155, 2005.

Bertorini TE.(Editor) Clinical Evaluation and Diagnostic Tests for Neuromuscular Disorders. Butterworth-Heinemann, Amsterdam, 2002.

Bertorini TE. Perisurgical management of patients with neuromuscular disorders. Perioerative Management and Preoperative assessment of neurologic diseases. Néstor Gálvez-Jiménez (ed.), In Neurologic Clinics of North America, Elsevier Saunders, Volume 22 (2) : pp. 293-313, 2004.

Bertorini TE. Chapter: Peripheral Sensory Conduction Studies, in Clinical Neurophysiology of Peripheral Nerve Diseases, Volume of Clinical Neurophysiology Handbook. Daulbe J and Mauguire F (eds). Elsevier. 2006.